CPS

Generational Equity Advises Canadian Payroll Services in its Sale to Vensure Employer Solutions

Retrieved on: 
Wednesday, December 20, 2023

Generational Equity , a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of its client Canadian Payroll Services, Inc. (CPS) to Vensure Employer Solutions.

Key Points: 
  • Generational Equity , a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of its client Canadian Payroll Services, Inc. (CPS) to Vensure Employer Solutions.
  • Vensure Employer Solutions is the largest privately held organization in the HR technology and service sector, providing a comprehensive portfolio of solutions, including HR/HCM technology, managed services, and global business process outsourcing (BPO).
  • The company and its service providers collectively serve over 95,000 businesses and process over $135B in annual payroll.
  • “The acquisition of CPS further solidifies our presence in the Canadian market,” said Alex Campos, CEO of Vensure Employer Solutions.

NIQ Catalyzes Growth with Strategic Leadership Appointment to Drive Innovation in Consumer Panel Services

Retrieved on: 
Tuesday, December 19, 2023

NIQ, a pioneering force in consumer and market intelligence, is proud to announce the appointment of Kris Ewing as the Global President of Consumer Panel Services (CPS) to accelerate growth, foster innovation, and deliver client-centric solutions.

Key Points: 
  • NIQ, a pioneering force in consumer and market intelligence, is proud to announce the appointment of Kris Ewing as the Global President of Consumer Panel Services (CPS) to accelerate growth, foster innovation, and deliver client-centric solutions.
  • Ewing's elevation to the position of Global President of Consumer Panel Services is a testament to NIQ's commitment to elevating data-driven insights to unprecedented heights.
  • "I am incredibly excited about the opportunity to lead in this dynamic landscape,” said Kris Ewing, Global President of Consumer Panel Services at NIQ.
  • NIQ is strategically prioritizing the advancement of Consumer Panel Services across the organization, initiating a series of key actions:
    Fostering greater clarity for clients through the connection of Retail Measurement Services and Consumer Panel Services through dynamic, integrated views on NIQ Discover (launching in 2024).

IN THE BLACK NETWORK TO EXPAND FAST CHANNEL OFFERINGS WITH URBANFLIXTV SCRIPTED CATALOG

Retrieved on: 
Wednesday, December 20, 2023

UrbanflixTV content will be available on December 22, 2023 with the launch of a new FAST TV streaming channel airing 24/7 on ITBN.

Key Points: 
  • UrbanflixTV content will be available on December 22, 2023 with the launch of a new FAST TV streaming channel airing 24/7 on ITBN.
  • With ITBN's new UrbanflixTV streaming channel, viewers can access a diverse range of content that reflects the real world with stories that resonate with Black and multicultural audiences.
  • "IN THE BLACK NETWORK is more than just a network, it stands as a vibrant testament to the richness of Black culture and the boundless creativity it inspires," said Samantha Johnstone, Chief Operating Officer of IN THE BLACK NETWORK.
  • "UrbanflixTV and IN THE BLACK NETWORK are a match made in streaming," said Herb Kimble, Founder of UrbanflixTV.

Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business Update

Retrieved on: 
Monday, November 13, 2023

The net loss attributable to common shareholders for the third quarter of 2023 was $4.2 million, or $0.82 per basic share and per diluted share.

Key Points: 
  • The net loss attributable to common shareholders for the third quarter of 2023 was $4.2 million, or $0.82 per basic share and per diluted share.
  • Revenues for the third quarter of 2023 were $6.8 million, compared to $4.2 million for the same period in 2022.
  • Total research and development expenses for the third quarter of 2023 were $7.6 million, compared with $22.0 million for the same period in 2022.
  • Total general and administrative expenses for the third quarter of 2023 were $4.3 million, compared with $5.9 million for the same period in 2022.

Theriva™ Biologics Reports Third Quarter 2023 Operational Highlights and Financial Results

Retrieved on: 
Monday, November 13, 2023

ET -

Key Points: 
  • ET -
    ROCKVILLE, Md., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today reported financial results for the third quarter ended September 30, 2023, and provided a corporate update.
  • Third Quarter Ended September 30, 2023 Financial Results
    General and administrative expenses decreased to $212,000 for the three months ended September 30, 2023, from $2.4 million for the three months ended September 30, 2022.
  • Theriva Biologics will host a conference call on Monday, November 13, 2023, at 8:30 a.m.
  • ET to discuss its financial results for the quarter ended September 30, 2023 and provide a corporate update.

CPS Announces Third Quarter 2023 Earnings

Retrieved on: 
Thursday, November 9, 2023

Revenues for the third quarter of 2023 were $92.1 million, an increase of $1.8 million, or 2.0%, compared to $90.3 million for the third quarter of 2022.

Key Points: 
  • Revenues for the third quarter of 2023 were $92.1 million, an increase of $1.8 million, or 2.0%, compared to $90.3 million for the third quarter of 2022.
  • Total operating expenses for the third quarter of 2023 were $77.9 million compared to $56.0 million for the 2022 period.
  • Pretax income for the third quarter of 2023 was $14.2 million, compared to pretax income of $34.3 million in the third quarter of 2022.
  • During the third quarter of 2023, CPS purchased $322.4 million of new contracts compared to $318.4 million during the second quarter of 2023 and $468.2 million during the third quarter of 2022.

European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy for New First-Line Indications in Advanced HER2-Negative Gastric or GEJ Adenocarcinoma in Tumors Expressing PD-L1 (CPS ≥1) and Advanced Biliary Tract Cancer

Retrieved on: 
Monday, December 18, 2023

In patients whose tumors expressed PD-L1 (CPS ≥1), KEYTRUDA plus chemotherapy reduced the risk of death by 26% (HR=0.74 [95% CI, 0.65-0.84]; p

Key Points: 
  • In patients whose tumors expressed PD-L1 (CPS ≥1), KEYTRUDA plus chemotherapy reduced the risk of death by 26% (HR=0.74 [95% CI, 0.65-0.84]; p
  • Median OS was 13.0 months (95% CI, 11.6-14.2) for patients treated with KEYTRUDA plus chemotherapy vs 11.4 months (95% CI, 10.5-12.0) for chemotherapy alone.
  • Median OS was 12.7 months (95% CI, 11.5-13.6) for KEYTRUDA plus chemotherapy versus 10.9 months (95% CI, 9.9-11.6) for chemotherapy alone.
  • In KEYNOTE-859, the incidence of Grade 3-5 adverse reactions in patients with gastric cancer was 75% for KEYTRUDA plus chemotherapy and 70% for chemotherapy.

Two Phase 3 Trials of Datopotamab Deruxtecan Plus Durvalumab Initiated in Patients Across Two Breast Cancer Subtypes

Retrieved on: 
Monday, December 18, 2023

Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) being jointly developed by Daiichi Sankyo and AstraZeneca.

Key Points: 
  • Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) being jointly developed by Daiichi Sankyo and AstraZeneca.
  • TROPION-Breast04 is evaluating neoadjuvant datopotamab deruxtecan plus durvalumab followed by adjuvant durvalumab with or without chemotherapy in patients with stage II-III triple negative breast cancer (TNBC) or hormone receptor (HR) low, HER2 low or negative breast cancer.
  • TROPION-Breast05 is evaluating datopotamab deruxtecan alone and in combination with durvalumab in patients with locally recurrent inoperable or metastatic TNBC whose tumors express PD-L1 (CPS ≥ 10).
  • TROPION-Breast03 is evaluating datopotamab deruxtecan with and without durvalumab versus investigator’s choice of therapy in patients with stage I to III TNBC with residual disease after neoadjuvant therapy.

Tigo Energy Breaks Through 10 Million MLPE Devices Deployed Milestone

Retrieved on: 
Thursday, December 14, 2023

Tigo Energy, Inc. (NASDAQ: TYGO), a leading provider of intelligent solar and energy storage solutions, today announced that an Arizona solar company has installed and commissioned the 10 millionth Tigo TS4 device.

Key Points: 
  • Tigo Energy, Inc. (NASDAQ: TYGO), a leading provider of intelligent solar and energy storage solutions, today announced that an Arizona solar company has installed and commissioned the 10 millionth Tigo TS4 device.
  • Serving as one of the 100,000+ solar installations using devices from the Tigo TS4 family, a solar system from independently owned, Arizona-based Sunny Energy is now home to the 10 millionth TS4 deployed.
  • Since 2007, 3.5 GW of Tigo MLPE devices have been deployed across more than 100 countries on all seven continents, of which more than 1 GWh of daily solar production is monitored by Tigo Energy Intelligence .
  • “We have used Tigo optimizers and rapid shutdown devices since 2017, and now, their inverters,” said Joseph Cunningham, co-founder and director of operations at Sunny Energy.

Vensure Employer Solutions Acquires Canadian Payroll Services to Broaden Presence and Expand HR Services Across North America

Retrieved on: 
Thursday, December 14, 2023

Vensure Employer Solutions, a leading provider of HR/HCM technology, managed services, and global business process outsourcing, today announced its acquisition of Canadian Payroll Services (CPS).

Key Points: 
  • Vensure Employer Solutions, a leading provider of HR/HCM technology, managed services, and global business process outsourcing, today announced its acquisition of Canadian Payroll Services (CPS).
  • “The acquisition of CPS further solidifies our presence in the Canadian market,” said Alex Campos, CEO of Vensure Employer Solutions.
  • Since 2004, Vensure Employer Solutions has been a premier provider of HR services and technology for small and medium-sized businesses, maintaining a leading position in the industry.
  • Its presence in Canada marks a significant step in expanding its expertise and proven track record to businesses across North America.